Christopher Causey

Sits on 1 board. Last updated September 27, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.

3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Mar 30, 2026 United Therapeutics Corporation Option exercise +1,300 $119.76 $155,688
Mar 30, 2026 United Therapeutics Corporation Open-market sale โˆ’1,300 $604.64 $786,032
Mar 4, 2026 United Therapeutics Corporation Option exercise +20 $119.76 $2,395
Mar 4, 2026 United Therapeutics Corporation Open-market sale โˆ’20 $490.17 $9,803
Feb 25, 2026 United Therapeutics Corporation Option exercise +1,000 $119.76 $119,760
Feb 25, 2026 United Therapeutics Corporation Open-market sale โˆ’1,000 $520.00 $520,000
Jan 6, 2026 United Therapeutics Corporation Option exercise +1,000 $119.76 $119,760
Jan 6, 2026 United Therapeutics Corporation Open-market sale โˆ’1,000 $510.00 $510,000
Jan 2, 2026 United Therapeutics Corporation Option exercise +1,000 $119.76 $119,760
Jan 2, 2026 United Therapeutics Corporation Open-market sale โˆ’1,000 $500.01 $500,010
Nov 3, 2025 United Therapeutics Corporation Gift โˆ’450 โ€” โ€”
Sep 24, 2025 United Therapeutics Corporation Option exercise +1,000 $119.76 $119,760
Sep 24, 2025 United Therapeutics Corporation Open-market sale โˆ’1,000 $440.00 $440,000
Sep 2, 2025 United Therapeutics Corporation Option exercise +3,000 $132.30 $396,900
Sep 2, 2025 United Therapeutics Corporation Open-market sale โˆ’1,000 $419.63 $419,630

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.